The observation that this protein is expressed in high density in a wide variety of cancer cells, and that the density of the σ2R is higher in proliferating versus quiescent breast cancer cells, ushered in an era that focused on the development of σ2R ligands in the treatment and molecular imaging of cancer [7]. This evidence concerns the gene TMEM97 and breast carcinoma.